{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:56:35Z","timestamp":1773284195979,"version":"3.50.1"},"reference-count":19,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T00:00:00Z","timestamp":1700352000000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Key Research and Development Program of Anhui Province","award":["202204295107020003"],"award-info":[{"award-number":["202204295107020003"]}]},{"name":"the Key health Project of Anhui Province","award":["AHWJ2022a037"],"award-info":[{"award-number":["AHWJ2022a037"]}]},{"name":"the Distinguished Young Scholars Fund of Anhui Province","award":["2022AH020078"],"award-info":[{"award-number":["2022AH020078"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,10,26]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Nowadays, invasive prostate biopsy is the standard diagnostic test for patients with suspected prostate cancer (PCa). However, it has some shortcomings such as perioperative complications, economic and psychological burden on patients, and some patients may undergo repeated prostate biopsy. In this study protocol, our aim is to provide a non-invasive diagnostic strategy we call the \u2018prostate-specific membrane antigen (PSMA) combined model\u2019 for the diagnosis of PCa. If patients are diagnosed with PCa using PSMA combined model, we want to prove these patients can receive radical prostatectomy directly without prior prostate biopsies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The SNOTOB trial adopts a prospective, single-centre, single-arm, open-label study design. The PSMA combined model consists of a diagnostic model based on what we previously reported and\n                      <jats:sup>18<\/jats:sup>\n                      F-PSMA-1007 positron emission tomography\/CT (\n                      <jats:sup>18<\/jats:sup>\n                      F-PSMA-1007 PET\/CT) examinations in series. First, patients use the diagnostic model (online address:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ustcprostatecancerprediction.shinyapps.io\/dynnomapp\/\">https:\/\/ustcprostatecancerprediction.shinyapps.io\/dynnomapp\/<\/jats:ext-link>\n                      ) to calculate the risk probability of clinically significant PCa (csPCa). When the risk probability of csPCa is equal or greater than 0.60,\n                      <jats:sup>18<\/jats:sup>\n                      F-PSMA-1007 PET\/CT will be applied for further diagnosis. If patients are still considered as csPCa after\n                      <jats:sup>18<\/jats:sup>\n                      F-PSMA-1007 PET\/CT examinations, we define this condition as positive results of PSMA combined model. Subsequently, we will recommend these patients to accept radical prostatectomy without prostate biopsy directly. Finally, the diagnostic performance of PSMA combined model will be verified with the pathological results. Totally, 57 patients need to be enrolled in this clinical trial.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study was approved by the ethics committee of The First Affiliated Hospital of USTC (No. 2022KY-142). The results of this study will be published in peer-reviewed journals and reported at academic conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05587192\">NCT05587192<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-073983","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T02:15:25Z","timestamp":1700446525000},"page":"e073983","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Protocol for SNOTOB study: radical prostatectomy without prostate biopsy following\n                    <sup>18<\/sup>\n                    F-PSMA-1007 PET\/CT based on a diagnostic model: a single-centre, single-arm, open-label study"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05587192","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Changming","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qifei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Urology, Anhui Provincial Hospital, Anhui Medical University, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehan","family":"Liu","sequence":"additional","affiliation":[{"name":"Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9012-1110","authenticated-orcid":false,"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,19]]},"reference":[{"key":"2025121601363334000_13.11.e073983.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"2025121601363334000_13.11.e073983.2","doi-asserted-by":"crossref","unstructured":"Xia C , Dong X , Li H , et al . n.d. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chinese Medical Journal;135:584\u201390. doi:10.1097\/CM9.0000000000002108","DOI":"10.1097\/CM9.0000000000002108"},{"key":"2025121601363334000_13.11.e073983.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.09.042"},{"key":"2025121601363334000_13.11.e073983.4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.6004\/jnccn.2023.0014","article-title":"NCCN guidelines\u00ae insights: prostate cancer early detection, version 1.2023","volume":"21","author":"Moses","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"2025121601363334000_13.11.e073983.5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k3519","article-title":"Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis","volume":"362","author":"Ilic","year":"2018","journal-title":"BMJ"},{"key":"2025121601363334000_13.11.e073983.6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euo.2020.12.004","article-title":"Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: A systematic review and meta-analysis","volume":"4","author":"Mazzone","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"2025121601363334000_13.11.e073983.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-019-0212-4"},{"key":"2025121601363334000_13.11.e073983.8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bju.15039","article-title":"Comparison of complications after Transrectal and Transperineal prostate biopsy: a national population-based study","volume":"126","author":"Berry","year":"2020","journal-title":"BJU Int"},{"key":"2025121601363334000_13.11.e073983.9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/bju.13711","article-title":"Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided Transperineal prostate biopsy in patients with a previous negative biopsy","volume":"120","author":"Hansen","year":"2017","journal-title":"BJU Int"},{"key":"2025121601363334000_13.11.e073983.10","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMe2214658","article-title":"Reducing prostate cancer Overdiagnosis","volume":"387","author":"Gulati","year":"2022","journal-title":"N Engl J Med"},{"key":"2025121601363334000_13.11.e073983.11","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1038\/s41591-022-02132-3","article-title":"11 clinical trials that will shape medicine in 2023","volume":"28","author":"Arnold","year":"2022","journal-title":"Nat Med"},{"key":"2025121601363334000_13.11.e073983.12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.811866","article-title":"Construction and validation of a clinical predictive Nomogram for improving the cancer detection of prostate naive biopsy based on Chinese multicenter clinical data","volume":"11","author":"Tao","year":"2021","journal-title":"Front Oncol"},{"key":"2025121601363334000_13.11.e073983.13","doi-asserted-by":"crossref","unstructured":"Wang C-M , Yuan L , Liu X-H , et al . Developing a diagnostic model for predicting prostate cancer: a retrospective study based on Chinese multicenter clinical data. Asian J Androl September 22, 2023. doi:10.4103\/aja202342","DOI":"10.4103\/aja202342"},{"key":"2025121601363334000_13.11.e073983.14","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2016.26"},{"key":"2025121601363334000_13.11.e073983.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.234187"},{"key":"2025121601363334000_13.11.e073983.16","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical Prostatectomy and pelvic lymph node dissection: A multicenter prospective phase 3 imaging trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025121601363334000_13.11.e073983.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.002"},{"key":"2025121601363334000_13.11.e073983.18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.eururo.2021.11.019","article-title":"Radical Prostatectomy without prior biopsy following Multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography","volume":"82","author":"Meissner","year":"2022","journal-title":"Eur Urol"},{"key":"2025121601363334000_13.11.e073983.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-073983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:36:38Z","timestamp":1765877798000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-073983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,19]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bmjopen-2023-073983"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-073983","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}